Neuraxpharm Aims For Sales Of €400m By Year End

The Projected Total Represents Organic Growth Of 10%

 
• By Akriti Seth
  
Euro_Sign
Neuraxpharm’s presence in Europe has grown to nine countries • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business